Jun Chen
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research 86
- MicroRNA in disease regulation 60
- Oncology top 0.5%
- Lung Cancer Research Studies 51
- Cancer Immunotherapy and Biomarkers 40
- Pathology and Forensic Medicine top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 93
- Lung Cancer Diagnosis and Treatment 59
- Molecular Biology top 0.5%
- RNA modifications and cancer 66
- Circular RNAs in diseases 43
- Journals
- Frontiers in Oncology (17 papers)OncoTargets and Therapy (15 papers)Journal of Clinical Oncology (14 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Jun Chen
747 papers receiving 15.5k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Cancer Research 3.8k
- Oncology 3.8k
- Pathology and Forensic Medicine 2.1k
- Pulmonary and Respiratory Medicine 3.4k
- Molecular Biology 6.6k
Countries citing papers authored by Jun Chen
This map shows the geographic impact of Jun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Chen more than expected).
Fields of papers citing papers by Jun Chen
This network shows the impact of papers produced by Jun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Chen. The network helps show where Jun Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 32 | |
| 10 | Ano1 is a Prognostic Biomarker That is Correlated with Immune Infiltration in Colorectal Cancer | 2022 | 5 |
| 11 | 2021 | 48 | |
| 12 | Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis | 2020 | 1 |
| 13 | NLRP3 Regulated CXCL12 Expression in Acute Neutrophilic Lung Injury | 2020 | 1 |
| 14 | 2016 | 22 | |
| 15 | 2012 | 1 | |
| 16 | 2010 | 91 | |
| 17 | 2009 | 80 | |
| 18 | 2008 | 73 | |
| 19 | Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. | 2007 | 54 |
| 20 | 2004 | 18 |
About Jun Chen
Jun Chen is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 799 papers that have together received 15.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (93 papers), Cancer-related molecular mechanisms research (86 papers), RNA modifications and cancer (66 papers), MicroRNA in disease regulation (60 papers), Lung Cancer Diagnosis and Treatment (59 papers), Lung Cancer Research Studies (51 papers), Circular RNAs in diseases (43 papers) and Cancer Immunotherapy and Biomarkers (40 papers). The work is most often cited by research in Cancer Research (3.8k citations), Oncology (3.8k citations) and Pathology and Forensic Medicine (2.1k citations). Jun Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Lori A. Setton, Hongyu Liu, Qinghua Zhou, Yan Xu, André Veillette, Roger P. Simon, Hongyu Liu, Liufang Jing, Li Y and Ming Hu. Their work appears in journals such as Frontiers in Oncology, OncoTargets and Therapy, Journal of Clinical Oncology, Oncotarget and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.